Changes at FDA may speed drug approval process and increase off-label use.
Reh
M
M
D000328:Adult; D000367:Age Factors; D002648:Child; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004346:Drug Information Services / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D004363:Drug Utilization / Q000331:legislation & jurisprudence; D005378:Financial Support; D006801:Humans; D007255:Information Services / Q000331:legislation & jurisprudence*; D008389:Marketing of Health Services; D008495:Medical Oncology; D010818:Practice Patterns, Physicians'; D011643:Publishing; D019275:Radiopharmaceuticals; D014481:United States; D014486:United States Food and Drug Administration
D019275:Radiopharmaceuticals